openPR Logo
Press release

Europe Cancer Biomarkers Market Size 2021 Industry Growth, Trends and Analysis

07-13-2017 11:19 AM CET | Health & Medicine

Press release from: Market Data Forecast

According to the report “Europe Cancer Biomarkers Market,” published by Market Data Forecast, the global market is projected to reach USD 5.1 billion by 2021 from USD 3 billion in 2016, at a CAGR of 11.2% from 2016 to 2021.

Biomarkers have many potential applications in oncology, including risk assessment, screening, differential diagnosis, determination of prognosis, prediction of response to treatment, and monitoring of progression of disease. Because of the critical role that biomarkers play at all stages of disease, it is important that they undergo rigorous evaluation, including analytical validation, clinical validation, and assessment of clinical utility, prior to incorporation into routine clinical care.

Cancer biomarkers must undergo rigorous analytic and clinical validation. Clinical validity must be established before a biomarker is used in the clinic. A cancer biomarker refers to a substance or process that is indicative of the presence of cancer in the body. A biomarker may be a molecule secreted by a tumor or a specific response of the body to the presence of cancer. Genetic, epigenetic, proteomic, glycomic, and imaging biomarkers can be used for cancer diagnosis, prognosis, and epidemiology. Ideally, such biomarkers can be assayed in non-invasively collected biofluids like blood or serum.

Get comprehensive overviews of the Europe Cancer Biomarkers market: http://www.marketdataforecast.com/market-reports/europe-cancer-biomarkers-market-2241/

Europe Cancer Biomarkers market: Drivers & Restraints
The cancer diagnostics market is driven by increasing commonness of different forms of cancer, growing cancer awareness, support of government initiatives and funding, and rise in healthcare expenditure. The introduction of non-invasive screening methods and novel diagnostic biomarkers are likely to create new revenue streams and fuel the cancer diagnostics market over the next five years. However, vague reimbursement scenario in certain countries and lack of specificity and sensitivity threaten to obstruct the growth of the cancer diagnostics market.

Get accurate market forecast and analysis on the Europe Cancer Biomarkers market. Request a sample to stay up-to-date on the main trends affecting this market http://www.marketdataforecast.com/market-reports/europe-cancer-biomarkers-market-2241/request-sample

Europe Cancer Biomarkers market: Segmentation
Disease
• Prostate Cancer
• Breast Cancer
• Lung Cancer
• Colorectal Cancer
• Cervical Cancer
• Other Cancers

Services
• Sample Preparation
• Assay development
• Biomarkers validation and testing

Application
• Risk Assessment
• Development of molecular diagnostics
• Disease diagnosis
• Drug discovery
• Development and Drug formulation

Type
• Protein Biomarkers
• Genetic biomarkers
• genetic biomarkers

Profiling Technologies
• Omics technologies
o Genomics
o Proteomics
o Metabolomics
o Transcriptomics
o Pharmacogenomics
• Imaging technologies
• Immunoassays
• Cytogenetics
• Bioinformatics
• IVD multivariate index assays

From simple data collation through secondary and primary research toad-hoc research requests relating to specific information, we provide our services via customization. Get customization at http://www.marketdataforecast.com/market-reports/europe-cancer-biomarkers-market-2241/customize-report

Europe Cancer Biomarkers market: Overview
Lung cancer is expected to witness fastest growth over the forecast period. Growing number of diagnostic tests targeting EGFR and BRAF mutations, which act as an essential biomarker for diagnosis of non-small cell lung cancer are anticipated to accentuate the segment growth.

Epigenetics has gained high acceptance in field of cancer diagnostics. High amount of research is being undertaken by many players for the analysis of key epigenetic modification related to cancer for further development of biomarker targeting drugs. Increasing collaboration between and pharmaceutical companies for the development of novel drugs targeting epigenetic biomarkers is estimated to boost growth of this segment.

Europe Cancer Biomarkers market: Region-wise Outlook
Based on geography, the market is analysed under various countries namely, U.K., Germany, France, Italy and Spain. U.K. is leading the cancer biomarkers market due to high incidence of cancer cases.

Key Questions Answered
• What is the current and future Cancer Biomarkers market outlook worldwide? What trends are affecting the Europe market?
• What is the competitive landscape and market share of major players in the Cancer Biomarkers space in Europe?
• What are the key, high growth markets that Cancer Biomarkers manufacturers should expand into? Which market segments are growing the fastest?
• What are the unmet needs with the Cancer Biomarkers currently on the market? How will emerging technologies fulfil these unmet needs?
• What is physician perception and market outlook of Cancer Biomarkers?
• What are the challenges and barriers that have hindered widespread
adoption of Cancer Biomarkers?

Europe Cancer Biomarkers market: Key Players
Some of the major players in this market are Abbott Laboratories, Agendia Bv, Biocurex Inc, Biomerieux S.A., Biomoda Inc, Astellas Pharma Us Inc, Correlogic Systems Inc, Beckman Coulter Inc, Becton, Dickinson And Company, Clarient Inc, Diadexus Inc, Ambrilia Biopharma, Affymetrix Inc and Aureon Laboratories Inc.

Reasons to buy Europe Cancer Biomarkers market Report:
•Global, regional and country-level analysis and forecasts of the study market; providing Insights on the geographical areas in which this industry is prospering
• Segment-level analysis on basis of product type, application, colour along with market size forecasts and y-o-y estimations to detect key areas of industry growth in detail
•Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
•Study of macro and micro environmental factors that affect the market presented in an extensive strategic analyses section containing PESTLE and Porter’s Five Forces Analyses
•A comprehensive listing of key market players along with company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and Analyst overview to study and sustain the market environment
•Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
•Expertly devised Market Outlook along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

Checkout other related studies in the Molecular Diagnostics Segment:
Biomarkers Market: http://www.marketdataforecast.com/research-reports/healthcare/molecular-diagnostics-4/market-reports/global-biomarkers-market-192/

About Market Data Forecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more information, kindly visit, www.marketdataforecast.com.

502, Kakatiya's Empire,
Jubilee Gardens, Hyderabad,
Telangana, India.

Contact:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Europe Cancer Biomarkers Market Size 2021 Industry Growth, Trends and Analysis here

News-ID: 622836 • Views:

More Releases from Market Data Forecast

Steam Methane Reforming Market Share, Industry Analysis & Forecast Report 2024-2029.
Steam Methane Reforming Market Share, Industry Analysis & Forecast Report 2024-2 …
According to the latest research report published by Market Data Forecast, the global steam methane reforming market size was valued at USD 691.67 million in 2023 and is projected to reach USD 1004.13 million by 2029, growing at a CAGR of 6.41% during the forecast period 2024 to 2029. Steam reforming of methane mainly involves two reactions: the water gas shift reaction and the reforming reaction. In the latter case, natural
Telecom Tower Market is set for a Potential Growth
Telecom Tower Market is set for a Potential Growth
According to the latest research report published by Market Data Forecast, the global telecom tower market is predicted to reach USD 3.74 billion in 2024 and USD 7.07 billion by 2029, growing at a CAGR of 13.59% during the forecast period. Telecom towers are the backbone of any mobile telecommunications system. The telecom tower is a structure that houses a transceiver to maintain connection with thousands of mobile phones and the
Coke Oven Batteries Market Share, Industry Analysis & Forecast Report 2024-2029.
Coke Oven Batteries Market Share, Industry Analysis & Forecast Report 2024-2029.
According to the latest research report published by Market Data Forecast, the global coke oven batteries market was valued at US$ 5.66 billion in 2023 and is predicted to reach US$ 30.24 billion by 2029, with a CAGR of 32.22% during the forecast period 2024 - 2029. The coke oven battery includes battery machines and a group of coke ovens. Charging of coal into the furnace and unloading of coke from
Marketing Automation Software Market is set for a Potential Growth Worldwide
Marketing Automation Software Market is set for a Potential Growth Worldwide
According to the latest research report published by Market Data Forecast, global marketing automation software market is anticipated to be worth USD 12.89 billion by 2029 from USD 6.96 billion in 2024, growing at a CAGR of 13.12% from 2024 to 2029. The marketing automation software market is experiencing strong growth, driven by rising demand for streamlined marketing operations. HubSpot, Market, and Salesforce are the dominant players in the market, providing

All 5 Releases


More Releases for Cancer

Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose. Increase in incidence of target diseases like cancer is key driving factor which is expected to boost
Oncology Nutrition Market led to an unprecedented rise by 2025 : liver cancer, p …
Global Oncology Nutrition Market: Overview Cancer diagnosis creates myriad questions about diet and nutrition. Those pertain to if the food will make a patient feel sick to what should be ingested to fight cancer. This has spawned the oncology nutrition market which has been rising steadily due to the increasing cases of different types of cancer worldwide. During cancer treatment one needs to eat right in order to build up strength
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business. Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports. This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top